Janssen Therap Drug Patent Portfolio
Janssen Therap owns 1 orange book drug protected by 2 US patents Given below is the list of Janssen Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546428 | Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol | 19 Mar, 2029 | Active |
| US7498343 | Mycobacterial inhibitors | 01 Dec, 2026 | Active |
Latest Legal Activities on Janssen Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Janssen Therap.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8546428 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Aug, 2020 | US7498343 |
|
Patent Term Extension Certificate
Critical
| 04 Apr, 2017 | US7498343 |
| Notice of Final Determination -Eligible | 07 Dec, 2016 | US7498343 |
|
FDA Final Eligibility Letter
Critical
| 29 Jul, 2016 | US7498343 |
| transaction for FDA Determination of Regulatory Review Period | 28 Dec, 2015 | US7498343 |
| transaction for FDA Determination of Regulatory Review Period | 10 Dec, 2015 | US7498343 |
| Second letter to regulating agency to determine regulatory review period | 13 Mar, 2015 | US7498343 |
| Letter from FDA or Dept of Agriculture re PTE application | 27 Mar, 2014 | US7498343 |
| Initial letter Re: PTE Application to regulating agency | 21 Feb, 2014 | US7498343 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 01 Oct, 2013 | US8546428 |
|
Recordation of Patent Grant Mailed
Critical
| 01 Oct, 2013 | US8546428 |
|
Email Notification
Critical
| 12 Sep, 2013 | US8546428 |
|
Issue Notification Mailed
Critical
| 11 Sep, 2013 | US8546428 |
|
Application Is Considered Ready for Issue
Critical
| 27 Aug, 2013 | US8546428 |
Janssen Therap's Family Patents
Janssen Therap Drug List
Given below is the complete list of Janssen Therap's drugs and the patents protecting them.
1. Sirturo
Sirturo is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546428 | Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
19 Mar, 2029
(4 years from now)
| Active |
| US7498343 | Mycobacterial inhibitors |
01 Dec, 2026
(1 year, 10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sirturo's drug page